Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Leukaemia pill could be used to treat multiple sclerosis

  • Comment

A treatment for the most common type of multiple sclerosis (MS) could become available in the form of a pill, it has been revealed.

The pill, cladribine, which is already used to treat some forms of leukaemia, will be an alternative to the injections MS sufferers currently receive.

The chances of MS patients relapsing could be reduced by half if the new drug is taking a few times a year, a US trial found.

Unlike the MS injection, which can cause patients to bruise easily and develop anaemia and infections, the pill has few side-effects.

The results of the research are a ‘huge step forward’, an MS Society spokesman said.

An application to license the use of the treatment is expected imminently, but widespread access via the NHS is dependant on approval from NICE which will judge the cost effectiveness. However, availability of cladribine could be sped up as it is already used to treat other conditions.

Cladribine was used to treat ‘relapsing-remitting’ MS, suffered by 65% of patients, in the trial.

Those taking the pill were 55% less likely to suffer a relapse than those on the placebo pill and worsening disability was reduced by 30%.

  • Comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.

Related Jobs